Comparing the MicroRNA spectrum between serum and plasma.

Wang K, Yuan Y, Cho JH, McClarty S, Baxter D, Galas DJ. · 2012

Read Comparing the MicroRNA spectrum between serum and plasma. by Wang K, Yuan Y, Cho JH, McClarty S, Baxter D, Galas DJ. (2012) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc3409228.txt.

Introduction

Wang and co-workers compared tiny regulatory RNAs in blood serum and plasma in 2012, a practical question for disease testing. These microRNAs circulate in blood and their levels track cancers and other conditions, making them promising markers. Matched serum and plasma came from the same donors.

Serum consistently held higher microRNA concentrations than the paired plasma. Part of the gap traced to microRNAs released from platelets, suggesting the clotting that makes serum reshapes the RNA mix. Readings also varied with the measurement platform used. The authors caution that studies mixing sample types or platforms may reach false conclusions. Marker hunters, they say, must standardize before comparing numbers.

Catalog record

CREATORWang K, Yuan Y, Cho JH, McClarty S, Baxter D, Galas DJ.
YEAR2012
COLLECTIONPAPERS
FORMATTXT
FILE SIZE32 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC3409228

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Comparing the MicroRNA Spectrum between Serum and Plasma By Kai Wang, Yue Yuan, Ji-Hoon Cho, Sara McClarty, David Baxter, David J. Galas, Sunil K. Ahuja Published in: PLoS ONE DOI: 10.1371/journal.pone.0041561 ABSTRACT Abstract MicroRNAs (miRNAs) are small, non-coding RNAs that regulate various biological processes, primarily through interaction with messenger RNAs. The levels of specific, circulating miRNAs in blood have been shown to associate with various pathological conditions including cancers. These miRNAs have great potential as biomarkers for various pathophysiological conditions. In this study we focused on different sample types’ effects on the spectrum of circulating miRNA in blood. Using serum and corresponding plasma samples from the same individuals, we observed higher miRNA concentrations in serum samples compared to the corresponding plasma samples. The difference between serum and plasma miRNA concentration showed some associations with miRNA from platelets, which may indicate that the coagulation process may affect the spectrum of extracellular miRNA in blood. Several miRNAs also showed platform dependent variations in measurements. Our results suggest that there are a number of factors that might affect the measurement of circulating miRNA concentration. Caution must be taken when comparing miRNA data generated from different sample types or measurement platforms. INTRODUCTION Measuring the levels of specific analytes in bodily fluids, especially serum or plasma prepared from blood, is the most commonly used method in diagnosis. It is relatively noninvasive and in certain cases, with proper training and supervision, can be self-administered by patients for disease management (e.g. a blood sugar test). However, most of the current blood biomarkers are inadequate in specificity and sensitivity for definitive disease diagnosis. One of the major foci in biomedical research in the past few decades has been to identify biomarkers, or panels of biomarkers, in body fluids with clear disease association. Most of these activities are centered on identifying protein-based biomarkers; however, promise is still unfulfilled. MicroRNAs (miRNAs) are endogenous 17 to 23 nucleotide-long noncoding regulatory RNA molecules that modulate cellular messenger RNA (mRNA) and protein levels by interacting with specific mRNAs, usually at the 3′ untranslated region (UTR), through partial sequence complementation [1], [2]. Thus far, over 1,000 human miRNAs have been identified (miRBase, www.mirbase.org). Recently, a significant number of miRNAs have also been found outside of the cells, and the levels of some of these extracellular miRNAs in circulation have been linked to different pathophysiological conditions. Examples of this include the associations of miR-141 with prostate cancer, miR-499 with myocardial infarction, and miR-122 with drug-induced liver injury [3]–[7]. These findings raise the possibility of using the levels of specific miRNAs in circulation as biomarkers for different pathological conditions [8]–[12]. Compared to protein-based biomarkers, miRNA offers several advantages: the complexity of miRNA is much lower than that of proteins; the miRNAs are stable in various bodily fluids; the sequences of many miRNAs are conserved among different clinically relevant species; the expression of some miRNAs are restricted to specific tissues or biological stages. The levels of miRNAs can also be easily measured by various commonly used laboratory methods, including assorted signal amplification strategies [8]. Despite significant progress in identifying the association of specific circulating miRNAs in various diseases, factors that may affect the measurement of circulating miRNA concentrations have yet to be fully addressed. Previous reports on the exportation of miRNAs from cells raised the prospect that plasma and serum might exhibit some differences in their miRNA content. We obtained serum and corresponding plasma samples from 12 healthy individuals to investigate the possible effects of different types of blood sample preparation on miRNA measurement. Our results suggested that different blood sample preparation methods might affect the concentration measurement of individual circulating miRNAs. RESULTS Serum and plasma samples from 12 individuals, 6 males and 6 females, with ages ranging from 22 to 41, were used for our measurements. Various blood cell components were also collected from 6 (3 males and 3 females) of the 12 donors (Table 1). The general sample information and concentrations of isolated RNA are listed on Table 1. No significant association between RNA concentration with either the gender or the age of the donor was observed. However the sera showed a higher RNA concentration than the corresponding plasma samples (with a p value of 0.0312 calculated by two-sample t-test). WBC, RBC, and platelets had much higher RNA concentrations than either plasma or serum, as expected. Unlike the RNA from RBC or WBC, the pattern of platelet total RNA is similar to serum and plasma on bioanalyzer (Figure S1). [Table: General information on samples and measurement results.] Plasma and Serum Contained Significant Number of miRNAs a) miRNA measured by Taqman card The serum and plasma miRNA spectrum from 6 normal individuals (3 males and 3 females) was profiled with Taqman miRNA panel (Table 1). The number of detectable miRNA species from these samples ranged from 137 (in ID-6 plasma) to 234 (in ID-1 plasma) (Table 1). 106 miRNAs could be seen in all plasma samples, 118 in all serum samples, and 98 miRNAs could be seen in all plasma and serum samples tested (Table S1). No significant correlation between the number of detectable miRNA species with either the gender of the donor, the type of sample used (serum or plasma), or the RNA concentration was observed. Based on the 40-Ct values, there is no statistically significant difference between serum and plasma’s miRNA concentrations (p-value = 0.3991 from two-sample t-test) (Table S1 and Figure 1A). However, the serum samples always showed higher concentrations than plasma when we measured specific miRNA levels with individual QPCR Taqman primers regardless of the results from the initial Taqman card profiling, examples are shown in Figure 2. Based on the Taqman card measurement results, the most abundant miRNA species was miR-223 for all the serum samples and one of the plasma samples tested (Table S3). [Figure: Comparing the individual miRNA concentrations between serum and plasma.The average concentrations (40-Ct values) of detected miRNAs in all serum and plasma samples within each platform were plotted – each point represents the average from all individuals of a specific miRNA. The Y-axis represents the average miRNA concentrations in serum and X-axis is the average concentration of corresponding plasma. The results from Taqman are showed in panel A and Exiqon are showed in panel B.] [Figure: Examples of miRNA concentration differences between serum and plasma using individual Taqman QPCR primers.The sample IDs were listed on the X-axis and the miRNA concentrations were displayed on the Y-axis (in 40-Ct value). The miRNA IDs were indicated on top of the graph. Open bars represent plasma samples and the solid bars represent the corresponding serum samples. The values of standard derivation were obtained from three independent measurements. The original measurement results from Taqman card showed higher 40-Ct values since a pre-amplification step was employed. Two-way ANOVA was used to determine the statistical significance of the miRNA concentration differences between serum and plasma (p-values are shown in the figure).] The coefficient of variation (standard deviation/mean of concentration) for individual miRNA across samples from different donors was determined. Among the 6 plasma samples, miR-101 showed the highest concentration variation and miR-185 had the most consistent concentration (Table 2). In sera, miR-576-3p and miR-345 had the highest and lowest concentration variations, respectively.

Read the complete text